RPL7L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.088200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.945200E-01
Normal-vs-Stage2
7.739600E-01
Normal-vs-Stage3
5.132100E-02
Normal-vs-Stage4
2.141600E-01
Stage1-vs-Stage2
6.947400E-01
Stage1-vs-Stage3
9.047900E-02
Stage1-vs-Stage4
1.608980E-01
Stage2-vs-Stage3
1.273180E-01
Stage2-vs-Stage4
3.189900E-02
Stage3-vs-Stage4
2.002500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.994000E-01
Normal-vs-AfricanAmerican
8.925200E-01
Normal-vs-Asian
6.217000E-01
Caucasian-vs-AfricanAmerican
5.486600E-01
Caucasian-vs-Asian
6.195600E-01
AfricanAmerican-vs-Asian
4.669800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.913400E-01
Normal-vs-Female
8.452400E-01
Male-vs-Female
7.452800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.070600E-01
Normal-vs-Age(41-60Yrs)
8.743800E-01
Normal-vs-Age(61-80Yrs)
6.398400E-01
Normal-vs-Age(81-100Yrs)
9.520000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.331400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.361200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.126600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.953500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.832600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.563200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.041200E-01
Normal-vs-Daily Drinker
2.823400E-01
Normal-vs-Weekly Drinker
7.348200E-01
Normal-vs-Occasional Drinker
6.112600E-01
Normal-vs-Social Drinker
9.004200E-01
Non Drinker-vs-Daily Drinker
3.601400E-01
Non Drinker-vs-Weekly Drinker
4.464400E-01
Non Drinker-vs-Occasional Drinker
1.134430E-02
Non Drinker-vs-Social Drinker
2.232400E-01
Daily Drinker-vs-Weekly Drinker
1.844210E-01
Daily Drinker-vs-Occasional Drinker
5.798500E-03
Daily Drinker-vs-Social Drinker
8.596000E-02
Weekly Drinker-vs-Occasional Drinker
1.599410E-01
Weekly Drinker-vs-Social Drinker
7.265200E-01
Occasional Drinker-vs-Social Drinker
2.572400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.457800E-01
Normal-vs-Grade 2
1.314750E-01
Normal-vs-Grade 3
1.171210E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.855200E-01
Grade 1-vs-Grade 3
2.431800E-01
Grade 1-vs-Grade 4
3.457800E-01
Grade 2-vs-Grade 3
7.456800E-01
Grade 2-vs-Grade 4
1.314750E-01
Grade 3-vs-Grade 4
1.171210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.974800E-01
Normal-vs-NonDiabetic
7.247800E-01
Diabetic-vs-NonDiabetic
3.454600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.263900E-02
Normal-vs-NoPancreatitis
7.571600E-01
Pancreatitis-vs-NoPancreatitis
2.110000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.742800E-01
Normal-vs-N1
8.210800E-01
N0-vs-N1
8.075000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.711000E-01
Normal-vs-TP53-NonMutant
8.394200E-01
TP53-Mutant-vs-TP53-NonMutant
7.810400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
